Winterlight Labs Announces Collaboration with Alector

Winterlight Labs announced it is developing vocal biomarkers for monitoring disease progression in frontotemporal dementia patients in collaboration with Alector, a biotechnology company developing therapeutics for neurodegeneration.

Click here to learn more

Previous
Previous

CoHealth & OptiFold Cosmetics Finalists in Telus Pitch Competition

Next
Next

ANGLE PLC Raises $30M to Commercialize Liquid Biopsy for Ovarian Cancer